Literature DB >> 766956

The effects of gonadal irradiation in clinical radiation therapy: a review.

C C Lushbaugh, G W Casarett.   

Abstract

Recent improvements in radiation therapy of some malignancies in lower abdominal sites are leading to a prolongation of life in persons of child-bearing age. These successes require an evaluation of the possible undersirable consequences of the unavoidable gonadal irradiation that occurs in these cases. A review of radiobiological data from experimental animal studies and retrospective clinical studies suggests that in most instances human gonadal exposures in both sexes are insufficient to cause permanent sterility, because the exposures are fractionated and the total gonadal dose is much less than 600 rads. As a consequence, return of fertility must be anticipated, and the worrison questions of radiation-induced genetic damage in subsequent pregnancies must be addressed. This review did not substantiate this fear, because no case reports could be found of malformed infants among the progeny of previously irradiated parents. Some experimental studies suggest that radiation-damaged spermatogonia are self-destructive, but any evidence for this phenomenon in the ovary is nonexistent. We suggest that the difference between fact and theory here may be the mathematical result of the interplay of low probability for occurrences and the few patients who until now have survived long enough for study.

Entities:  

Mesh:

Year:  1976        PMID: 766956     DOI: 10.1002/1097-0142(197602)37:2+<1111::aid-cncr2820370821>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Prolonged amenorrhea associated with total nodal irradiation for Hodgkin's disease.

Authors:  M Y Halyard; J L Cornella; G L Grado; N R Rizzo
Journal:  J Natl Med Assoc       Date:  1996-06       Impact factor: 1.798

Review 2.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

3.  Strategies for reducing ovarian dose in volumetric modulated arc therapy (VMAT) for postoperative uterine cervical cancer.

Authors:  Ueda Yoshihiro; Ohira Shingo; Isono Masaru; Miyazaki Masayoshi; Konishi Koji; Kamiura Shoji; Sumida Iori; Ogawa Kazuhiko; Teshima Teruki
Journal:  Br J Radiol       Date:  2017-11-03       Impact factor: 3.039

Review 4.  Educational paper: the effect of cancer therapy on fertility, the assessment of fertility and fertility preservation options for pediatric patients.

Authors:  Jill P Ginsberg
Journal:  Eur J Pediatr       Date:  2010-12-04       Impact factor: 3.183

5.  Azoospermia after iodine-131 treatment for thyroid carcinoma.

Authors:  D J Handelsman; A J Conway; P E Donnelly; J R Turtle
Journal:  Br Med J       Date:  1980-12-06

Review 6.  [Radiation reactions in the gonads: importance in patient counseling].

Authors:  T Herrmann
Journal:  Strahlenther Onkol       Date:  1997-10       Impact factor: 3.621

Review 7.  Fertility preservation and management of gonadal failure associated with lymphoma therapy.

Authors:  Simon J Howell; Stephen M Shalet
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

8.  Childhood cancer, endocrine disorders, and cohort studies.

Authors:  Kevin C Oeffinger; Charles A Sklar
Journal:  Lancet       Date:  2014-02-18       Impact factor: 79.321

Review 9.  Thyroid disease and male reproductive function.

Authors:  G E Krassas; P Perros
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

Review 10.  Fertility preservation in the male with cancer.

Authors:  Daniel H Williams
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.